Ascendis Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	13,836	13,089	8,238	7,123	6,832	7,369
Market Cap Growth	-	58.87%	15.65%	4.26%	-7.28%	-17.80%
Enterprise Value	14,099	12,818	8,036	6,928	6,562	6,705
Last Close Price	223.96	213.24	137.67	125.95	122.14	134.54
PE Ratio	-	-48.34	-20.26	-13.33	-10.95	-16.90
PS Ratio	16.32	15.49	21.77	24.16	124.47	833.13
PB Ratio	-	-68.52	-74.90	-44.23	24.19	7.33
P/TBV Ratio	-84.55	-79.37	-75.40	-48.66	26.01	8.34
P/FCF Ratio	259.54	245.65	-25.74	-13.72	-12.48	-14.68
P/OCF Ratio	218.05	206.98	-25.86	-13.79	-12.85	-15.52
EV/Sales Ratio	16.67	15.17	21.24	23.50	119.53	758.03
EV/EBITDA Ratio	-	-92.14	-29.58	-14.35	-11.25	-13.51
EV/EBIT Ratio	-	-80.17	-27.70	-13.76	-10.89	-13.05
EV/FCF Ratio	265.19	240.57	-25.10	-13.34	-11.99	-13.36
Debt / Equity Ratio	-2.37	-2.37	-3.45	-1.53	1.83	0.11
Debt / EBITDA Ratio	-7.35	-7.35	-3.28	-1.48	-0.93	-0.24
Debt / FCF Ratio	19.20	19.20	-2.78	-1.37	-1.00	-0.24
Net Debt / Equity Ratio	-1.57	-1.57	-2.81	-1.68	-0.86	-0.65
Net Debt / EBITDA Ratio	-2.16	-2.16	-1.14	-0.56	0.42	1.32
Net Debt / FCF Ratio	5.63	5.63	-0.97	-0.52	0.45	1.31
Asset Turnover	0.58	0.58	0.36	0.28	0.05	0.01
Inventory Turnover	0.01	0.32	0.18	-0.26	0.12	0.09
Quick Ratio	0.72	0.72	0.81	0.62	4.44	7.03
Current Ratio	1.04	1.04	1.17	0.95	5.39	8.03
Return on Equity (ROE)	169.84%	169.84%	300.78%	-818.43%	-101.69%	-44.54%
Return on Assets (ROA)	-11.77%	-11.77%	-28.17%	-48.30%	-52.15%	-43.72%
Return on Invested Capital (ROIC)	-26.11%	-26.11%	-66.04%	-158.18%	-190.06%	-154.96%
Return on Capital Employed (ROCE)	-53.99%	-53.99%	-154.56%	-90.43%	-59.04%	-47.27%
Earnings Yield	-1.94%	-2.07%	-4.94%	-7.50%	-9.13%	-5.92%
FCF Yield	0.39%	0.41%	-3.89%	-7.29%	-8.01%	-6.81%
Buyback Yield / Dilution	-4.69%	-4.69%	-2.85%	-0.38%	-2.37%	-8.21%
Total Shareholder Return	-4.69%	-4.69%	-2.85%	-0.38%	-2.37%	-8.21%

Updated Feb 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q